APOE and Alzheimer disease: Other studies finding increased prevalence of H63D HFE in AD patients only reached significance in those also carrying ApoE4 [92] or only in female ApoE4 carriers, while finding a decreased prevalence of H63D HFE in male ApoE4 AD patients [93].